LOGO
LOGO

Corporate News

Tenax Therapeutics Shares Rise 19% Despite Wider Q4 Loss

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Tenax Therapeutics, Inc. (TENX) shares climbed 19.15 percent to $13.13, gaining $2.11 on Tuesday even after the company reported a wider loss for the fourth quarter.

The stock is currently trading at $13.13 compared with its previous close of $11.02. Shares opened at $12.00 and traded between $12.00 and $13.82 during the session on the Nasdaq. Trading volume reached about 710,320 shares, higher than the average volume of about 257,049 shares.

Tenax reported a fourth-quarter net loss of $15.54 million, or $0.38 per share, compared with a net loss of $6.27 million, or $0.18 per share, a year earlier. Operating expenses rose to $16.45 million from $7.30 million, driven by higher research and development spending. For the full year 2025, the company posted a net loss of $52.60 million, or $1.34 per share, versus a loss of $17.60 million, or $1.15 per share, in 2024. The stock has traded in a 52-week range of $4.63 to $18.38.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

RELATED NEWS
Latest Updates on COVID-19